Buscar
01/03/2025
Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties
Martin, IJP, Guzmán, EF, Polo, MM, Martin, MA, Pascual, EF, Samaniego, MP, Pascual, EM, González, AR, González, BM, Sanz, IP, Jimenez, CP, Bonilla, AS, Morcillo, JCR, Fes, E, Suárez, JMG, Ortega, JL, Roca, JPD, Juanatey, FC. Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series
Territo, A, Afferi, L, Musquera, M, Sopena, HMG, Pecoraro, A, Campi, R, Gallioli, A, Etcheverry, B, Prudhomme, T, Vangeneugden, J, Ortved, M, Roder, A, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Mirza,, Fornara, P, Doumerc, N, Decaestecker, K, Serni, S, Vigues, F, Alcaraz, A, Breda, A. Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU)
De Oliveira, TMR, Somani, B, Browers, T, Veneziano, D, Redorta, JP, Biyani, CS, Kallidonis, P, Kasivisvanathan,, Zondervan, P, Petrut, B, Verze, P, Phe, VR, Raison, N, Silay, MS, Larche, A, Boissier, R, Liatsikos, E. SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU). EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2025
A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress
Guerrero-Ramos, F, Chang, S, Dickstein, RJ, Jayram, G, Johnson, S, Joshi, S, Liu, JJ, Lotan, Y, Marcq, G, Satkunasivam, R, Schuckman, A, Steinberg, G, Taylor, J, Linback, T, Pruthi, R, Cheung, A, Tosone, C, Kamat, AM, Palou, J. A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).